Latest News

A study led by scientists of the German Centre for Cardiovascular Research (DZHK) at the Rhine-Main partner site found that the risk of major adverse cardiac events in patients with coronary artery disease can be substantially better assessed with a short MRI examination than...

Recently, all 17 hospitals that are members of the German Centre for Cardiovascular Research (DZHK) have had cardiovascular clinical research units at their disposal. These units that have been equipped by the DZHK are solely for the examination of patients participating in...

Atrial fibrillation ablation with continuous Apixaban does not increase the risk of stroke or bleeding compared to vitamin K antagonists and may have a positive effect on cognitive function. These are the key findings from the investigator-initiated clinical trial AXAFA – AFNET...

Congenital heart defects (CHD) are severe chronic diseases. Yet most patients with chronic heart disease aged between ten and thirty assess their own health as good to very good. Moreover, they barely feel impaired in their everyday lives. Only very few patients make use of...

Fear protects people from danger. A team from Helmholtz Zentrum München and the Technical University of Munich (TUM) has discovered that this applies even to pathological anxiety disorders. Patients who generally suffer from severe anxiety are likely to heed the symptoms of a...

The German Centre for Cardiovascular Disease (DZHK) has announced a new €12 million partnership with the British Heart Foundation, to fund ground-breaking research and foster international collaboration.

The outcome of viral myocarditis is closely associated with the immune response of the affected individual. An inhibitor of the immunoproteasome, a protein degradation complex in immunocompetent cells, reduces the extent of the inflammation and thus also the damage to the heart...